CDK5RAP3 and head and neck squamous cell carcinoma: CDK5RAP3 has been reported to bind with RelA and suppress the NF-κB pathway through the LXXLL/leucine zipper-containing alternative reading frame (ARF) to repress head and neck squamous cell carcinoma [8, 9].